Akorn (AKRX) Files Shelf Offering of Up To 13.3M Shares
More News related to AKRX
- Akorn (AKRX) Posts Q3 Loss of $0.06, Beats By 2c
- Akorn Reports Third Quarter 2009 Financial Results; Launches Two New Products: Ketorolac Tromethamine Ophthalmic and Hydralazine HCL
- Trading Radar for 11/10: Tyco Int. (TYC), ArvinMeritor (ARM), Clearwire (CLWR), American Apparel (APP) Report
- Akorn, Inc. Announces Third Quarter 2009 Earnings Release and Conference Call Information
- Akorn (AKRX) Files Shelf Offering of Up To 13.3M Shares
More News related to Corporate News
- Nymox Pharmaceutical (NYMX) Announces Positive Clinical Data on BPH Drug NX-1207
- ARCA Biopharma (ABIO) Annouces Gencaro OK'd by U.S. FDA for Fast Track Program
- Ception and Cephalon (CEPH) Report Initial Results from Phase IIb/III Trial for CINQUIL(TM)
In an S-3 after the close, Akorn (Nasdaq: AKRX) filed to sell up to 13,310,226 shares.
Related Categories
Corporate NewsEquity Offerings
Stocks Mentioned
+0.07Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
